Skip to main content
. 2017 Nov 9;18(11):2151. doi: 10.3390/ijms18112151

Table 4.

Sensitivity obtained for different working conditions checked in the assessment of assay time shortening.

b-DNACp-MBs-Mixture Solution Incubation Time, min [Anti DNA–RNA Hybrid Antibody], µg·mL−1 [ProtA–HRP40], μg·mL−1 Slope, nA·nM1 Sensitivity, %
30 2.0 2.0 55,214 ± 921 100
15 2.0 2.0 34,843 ± 2542 63.1
4.0 2.0 30,844 ± 4494 55.9
2.0 4.0 53,899 ± 659 97.6
4.0 4.0 48,862 ± 4269 88.5